Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medtronic, a medical technology company, has completed the acquisition of privately held Ablation Frontiers, an atrial fibrillation catheter company.
Subscribe to our email newsletter
Under the terms of the agreement, the transaction includes an initial payment of $225 million plus potential additional payments contingent upon achievement of certain clinical milestones.
Operating within Medtronic’s cardiac rhythm disease management business, Ablation Frontiers and the recently acquired CryoCath Technologies are believed to expand the company’s recently launched atrial fibrillation solutions business.